Based on the Galapagos NV ADR stock forecast from 2 analysts, the average analyst target price for Galapagos NV ADR is USD 26.43 over the next 12 months. Galapagos NV ADR’s average analyst rating is Under-perform. Stock Target Advisor’s own stock analysis of Galapagos NV ADR is Neutral, which is based on 6 positive signals and 6 negative signals. At the last closing, Galapagos NV ADR’s stock price was USD 23.88. Galapagos NV ADR’s stock price has changed by +1.53% over the past week, -8.19% over the past month and -19.02% over the last year.
No recent analyst target price found for Galapagos NV ADR
No recent average analyst rating found for Galapagos NV ADR
Company Overview Galapagos NV ADR
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium. Read Less
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at p...Read More
Frequently Asked Questions About Galapagos NV ADR (GLPG) Stock
Based on ratings from 2 analysts Galapagos NV ADR's stock is Under-perform. Stock Target Advisor's fundamental analysis is Neutral. The stock has buy, 4 sell and 3 hold ratings.
Unfortunately we do not have enough data on GLPG's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for GLPG is USD 26.43 over the next 12 months. The maximum analyst target price is USD 31 while the minimum anlayst target price is USD 22.
GLPG stock's Price/Earning ratio is 57.65.
Our analysis grades GLPG stock's Price / Earning ratio at F. This means that GLPG stock's Price/Earning ratio is above 84% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this GLPG may be a overvalued for its sector.
The last closing price of GLPG's stock was USD 23.88.
The most recent market capitalization for GLPG is USD 1.59B.
Based on targets from 2 analysts, the average taret price for GLPG is projected at USD 26.43 over the next 12 months.
This means that GLPG's stock price may go up by +10.67% over the next 12 months.
We can't find any ETFs which contains Galapagos NV ADR's stock.
As per our most recent records Galapagos NV ADR has 704 Employees.
Galapagos NV ADR's registered address is Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800.
You can get more information about it from Galapagos NV ADR's website at https://www.glpg.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Frequently Asked Questions About Galapagos NV ADR (GLPG) Stock
Based on ratings from 2 analysts Galapagos NV ADR's stock is Under-perform. Stock Target Advisor's fundamental analysis is Neutral. The stock has buy, 4 sell and 3 hold ratings.
Unfortunately we do not have enough data on GLPG's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for GLPG is USD 26.43 over the next 12 months. The maximum analyst target price is USD 31 while the minimum anlayst target price is USD 22.
GLPG stock's Price/Earning ratio is 57.65.
Our analysis grades GLPG stock's Price / Earning ratio at F. This means that GLPG stock's Price/Earning ratio is above 84% of the stocks in the Biotechnology sector in the NSD exchange.
Based on this GLPG may be a overvalued for its sector.
The last closing price of GLPG's stock was USD 23.88.
The most recent market capitalization for GLPG is USD 1.59B.
Based on targets from 2 analysts, the average taret price for GLPG is projected at USD 26.43 over the next 12 months.
This means that GLPG's stock price may go up by +10.67% over the next 12 months.
We can't find any ETFs which contains Galapagos NV ADR's stock.
As per our most recent records Galapagos NV ADR has 704 Employees.
Galapagos NV ADR's registered address is Generaal De Wittelaan L11 A3, Mechelen, Belgium, 2800.
You can get more information about it from Galapagos NV ADR's website at https://www.glpg.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GLPG !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
